2007
DOI: 10.3109/9781420017137.003
|View full text |Cite
|
Sign up to set email alerts
|

In Vitro Dynamic Models as Tools to Predict Antibiotic Pharmacodynamics

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
4
0

Year Published

2008
2008
2018
2018

Publication Types

Select...
5
1

Relationship

4
2

Authors

Journals

citations
Cited by 7 publications
(4 citation statements)
references
References 114 publications
0
4
0
Order By: Relevance
“…With the two strains of S. aureus that exhibit four-fold different MPC/MIC ratios, this enrichment was concentration-dependent: the higher the AUC 24 /MIC, the later [5,8,16]. It is very likely that with both S. aureus ATCC 43300 and ATCC 6538 the lowest simulated AUC 24 /MIC relates to the end of the ascending portion (close to the top of the bell) and the two higher AUC 24 /MICs to the descending portion of the bell curve.…”
Section: Discussionmentioning
confidence: 95%
“…With the two strains of S. aureus that exhibit four-fold different MPC/MIC ratios, this enrichment was concentration-dependent: the higher the AUC 24 /MIC, the later [5,8,16]. It is very likely that with both S. aureus ATCC 43300 and ATCC 6538 the lowest simulated AUC 24 /MIC relates to the end of the ascending portion (close to the top of the bell) and the two higher AUC 24 /MICs to the descending portion of the bell curve.…”
Section: Discussionmentioning
confidence: 95%
“…Over the last 5 years, this phenomenon has been studied intensively in vitro by using dynamic models; the results of these studies have recently been reviewed and discussed in detail elsewhere (9). Previously reported complex relationships between the enrichment of resistant mutants and in vitro-simulated pharmacokinetics of fluoroquinolones (5)(6)(7)16) and glycopeptides (8) support the hypothesis of the mutant selection window (MSW) (14).…”
mentioning
confidence: 88%
“…Given a growing number of clinical reports on the isolation of resistant pathogens combined with a weak antibiotic pipeline [2], the development of new compounds is currently aimed at the suppression and/or restriction of resistance [3,4]. Given that the enrichment of resistant mutants with concomitant loss in pathogen susceptibility should be concentration-dependent, concentration-resistance relationships are the methodological basis on which so-called "anti-mutant" antibiotic dosing regimens can be designed [5]. Such a relationship was first established in an in vitro study with fluoroquinolone-exposed Staphylococcus aureus using a dynamic model that simulates human antibiotic pharmacokinetics [6].…”
Section: Introductionmentioning
confidence: 99%